Antheia
The Research Associate DSP at Antheia will focus on understanding impurity fate, product stability, and degradation mechanisms while managing unit operations and data collection to develop scalable processes for separating and purifying bio-derived starting materials and APIs from bench to pilot scale. The role involves cross‑functional collaboration with biology, analytics, operations, quality, and regulatory teams to ensure sustainable, in‑specification product production.
Headquarters
Menlo Park, California, United States
Company Size
11-50 employees
Founded
2015
Antheia is a next‑generation synthetic biology company that manufactures pharmaceutical ingredients using engineered biology and advanced bioprocessing. They aim to transform pharmaceutical supply chains to end drug shortages and provide more reliable, sustainable access to complex active ingredients. By combining molecule development and scalable biosynthesis, Antheia seeks to accelerate drug development and unlock new discovery opportunities for pharma partners.
Antheia Raises Additional $24 Million to Complete Series C Financing, Bringing Total Funds Raised to More than $175 Million Over Past Year
1 month ago
Antheia Raises $56M Series C to Alleviate Global Drug Shortages with Synthetic Biology
Jun 3, 2025
Antheia Secures Additional Funding from HHS to Onshore Supply Chains
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Antheia.
27% above the average for this role
Antheia seals 2nd series C funding close, hitting more than $175M in a year
1 month ago